Literature DB >> 19945296

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.

Manjunatha M Venkataswamy1, Steven A Porcelli.   

Abstract

In spite of their relatively limited antigen receptor repertoire, CD1d-restricted NKT cells recognize a surprisingly diverse range of lipid and glycolipid antigens. Recent studies of natural and synthetic CD1d-presented antigens provide an increasingly detailed picture of how the specific structural features of these lipids and glycolipids influence their ability to be presented to NKT cells and stimulate their diverse immunologic functions. Particularly for synthetic analogues of alpha-galactosylceramides which have been the focus of intense recent investigation, it is becoming clear that the design of glycolipid antigens with the ability to precisely control the specific immunologic activities of NKT cells is likely to be feasible. The emerging details of the mechanisms underlying the structure-activity relationship of NKT cell antigens will assist greatly in the design and production of immunomodulatory agents for the precise manipulation of NKT cells and the many other components of the immune system that they influence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945296      PMCID: PMC2837800          DOI: 10.1016/j.smim.2009.10.003

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  97 in total

1.  NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.

Authors:  Adam P Uldrich; Nadine Y Crowe; Konstantinos Kyparissoudis; Daniel G Pellicci; Yifan Zhan; Andrew M Lew; Philippe Bouillet; Andreas Strasser; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo.

Authors:  Jelena S Bezbradica; Aleksandar K Stanic; Naoto Matsuki; Helene Bour-Jordan; Jeffrey A Bluestone; James W Thomas; Derya Unutmaz; Luc Van Kaer; Sebastian Joyce
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

3.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

Authors:  Dirk M Zajonc; Carlos Cantu; Jochen Mattner; Dapeng Zhou; Paul B Savage; Albert Bendelac; Ian A Wilson; Luc Teyton
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

Review 4.  The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy.

Authors:  Karl O A Yu; Steven A Porcelli
Journal:  Immunol Lett       Date:  2005-08-15       Impact factor: 3.685

5.  Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.

Authors:  Rachel M Ndonye; Douglas P Izmirian; Matthew F Dunn; Karl O A Yu; Steven A Porcelli; Archana Khurana; Mitchell Kronenberg; Stewart K Richardson; Amy R Howell
Journal:  J Org Chem       Date:  2005-12-09       Impact factor: 4.354

6.  Apolipoprotein-mediated pathways of lipid antigen presentation.

Authors:  Peter van den Elzen; Salil Garg; Luis León; Manfred Brigl; Elizabeth A Leadbetter; Jenny E Gumperz; Chris C Dascher; Tan-Yun Cheng; Frank M Sacks; Petr A Illarionov; Gurdyal S Besra; Sally C Kent; D Branch Moody; Michael B Brenner
Journal:  Nature       Date:  2005-10-06       Impact factor: 49.962

7.  The crystal structure of human CD1d with and without alpha-galactosylceramide.

Authors:  Michael Koch; Victoria S Stronge; Dawn Shepherd; Stephan D Gadola; Bini Mathew; Gerd Ritter; Alan R Fersht; Gurdyal S Besra; Richard R Schmidt; E Yvonne Jones; Vincenzo Cerundolo
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

8.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Authors:  Jochen Mattner; Kristin L Debord; Nahed Ismail; Randal D Goff; Carlos Cantu; Dapeng Zhou; Pierre Saint-Mezard; Vivien Wang; Ying Gao; Ning Yin; Kasper Hoebe; Olaf Schneewind; David Walker; Bruce Beutler; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

9.  Recognition of bacterial glycosphingolipids by natural killer T cells.

Authors:  Yuki Kinjo; Douglass Wu; Gisen Kim; Guo-Wen Xing; Michael A Poles; David D Ho; Moriya Tsuji; Kazuyoshi Kawahara; Chi-Huey Wong; Mitchell Kronenberg
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

10.  Differential antitumor immunity mediated by NKT cell subsets in vivo.

Authors:  Nadine Y Crowe; Jonathan M Coquet; Stuart P Berzins; Konstantinos Kyparissoudis; Rachael Keating; Daniel G Pellicci; Yoshihiro Hayakawa; Dale I Godfrey; Mark J Smyth
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

View more
  60 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 3.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

4.  Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.

Authors:  Li Bai; Shenglou Deng; Rachel Reboulet; Rebecca Mathew; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

5.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

Review 6.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

7.  A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.

Authors:  Kwok S Wun; Garth Cameron; Onisha Patel; Siew Siew Pang; Daniel G Pellicci; Lucy C Sullivan; Santosh Keshipeddy; Mary H Young; Adam P Uldrich; Meena S Thakur; Stewart K Richardson; Amy R Howell; Petr A Illarionov; Andrew G Brooks; Gurdyal S Besra; James McCluskey; Laurent Gapin; Steven A Porcelli; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

Review 8.  Control of early stages in invariant natural killer T-cell development.

Authors:  Taishan Hu; Idoia Gimferrer; José Alberola-Ila
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

9.  iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .

Authors:  Hamid Bassiri; Rupali Das; Peng Guan; David M Barrett; Patrick J Brennan; Pinaki P Banerjee; Susan J Wiener; Jordan S Orange; Michael B Brenner; Stephan A Grupp; Kim E Nichols
Journal:  Cancer Immunol Res       Date:  2014-01       Impact factor: 11.151

Review 10.  Recognition of CD1d-restricted antigens by natural killer T cells.

Authors:  Jamie Rossjohn; Daniel G Pellicci; Onisha Patel; Laurent Gapin; Dale I Godfrey
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.